Prof. Urszula Wojda is a member of an international consortium that has received a EU Horizon 2020 grant in the FETOPEN: Research & Innovation Action, Novel Ideas for Radically New Technologies competition. The aim of the consortium’s research is to develop new strategies for the treatment and diagnosis of Alzheimer's disease based on studies of glycobiological alterations in AD. The “ArrestAD” project received the highest possible evaluation of reviewers (15/15).

The consortium of the "ArrestAD" project includes the following entities:

Consortium leader: UNIVERSITE PARIS XII VAL DE MARNE FR

THE UNIVERSITY OF LIVERPOOL UK

STICHTING KATHOLIEKE UNIVERSITEIT NL

INSTYTUT BIOLOGII DOSWIADCZALNEJ IM. M. NENCKIEGO POLSKIEJ AKADEMII NAUK PL

FUNDACION DE INVESTIGACION DEL CANCER DE LA UNIVERSIDAD DE SALAMANCA ES

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS FR

UNIVERSITAT AUTONOMA DE BARCELONA ES

SCREENCELL Company

Prof. Urszula Wojda with her group from the Laboratory of Preclinical Studies of Higher Standard of the Neurobiology Centre at the Nencki Institute will be examining the relationships between genetic and proteomic factors of AD and changes of glycosaminoglycans in blood cells, as a basis for developing new strategies for the early diagnosis of AD. Blood samples for the research will be provided by Prof. Thomas Gabryelewicz’s team from the Alzheimer’s Ward of the Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw.